The role of gut microbiota in the pharmacokinetics of antihypertensive drugs

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmacological Research

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.phrs.2018.01.019PMID 29391236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carboxylesterases: Sources, Characterizationand Broader Applications

  2018cited by this paper
• The influence of gut microbiota on drug metabolism and toxicity

  2016cited by this paper
• Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction

  2016cited by this paper
• Lactobacillus acidophilus stimulates intestinal P-glycoprotein expression via a c-Fos/c-Jun-dependent mechanism in intestinal epithelial cells.

  2016cited by this paper
• Global burden of cardiovascular disease and stroke: hypertension at the core.

  2015cited by this paper
• Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology?

  2015cited by this paper
• Special Section on Drug Metabolism and the Microbiome—Perspective Gut Microbiota-Mediated Drug-Antibiotic Interactions

  2015cited by this paper
• The gut microbiome in health and in disease

  2015cited by this paper
• Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.

  2014cited by this paper
• Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

  2014cited by this paper
• Amlodipine Metabolism in Human Liver Microsomes and Roles of CYP3A4/5 in the Dihydropyridine Dehydrogenation

  2014cited by this paper
• Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats

  2014cited by this paper
• Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.

  2014cited by this paper
• The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs.

  2014cited by this paper
• A pharmacokinetic drug-drug interaction model of simvastatin and clarithromycin in humans

  2014cited by this paper
• Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics

  2014cited by this paper
• In vitro fermentation of lactulose by human gut bacteria.

  2014cited by this paper
• Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin

  2014cited by this paper
• Erratum to: Overexpression, Purification, and Biochemical Characterization of the Esterase Est0796 from Lactobacillus plantarum WCFS1

  2013cited by this paper
• A Novel Alkaliphilic Bacillus Esterase Belongs to the 13th Bacterial Lipolytic Enzyme Family

  2013cited by this paper
• The effect of gut microbiota on drug metabolism

  2013cited by this paper
• The gut microbiota — masters of host development and physiology

  2013cited by this paper
• Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes

  2012cited by this paper
• Xenobiotic metabolomics: major impact on the metabolome.

  2012cited by this paper
• Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats.

  2012cited by this paper
• Overexpression, Purification, and Biochemical Characterization of the Esterase Est0796 from Lactobacillus plantarum WCFS1

  2012cited by this paper
• Metabolic Activities of Ginseng and Its Constituents, Ginsenoside Rb1 and Rg1, by Human Intestinal Microflora

  2011cited by this paper
• Bacteroides uniformis is a putative bacterial species associated with the degradation of the isoflavone genistein in human feces.

  2011cited by this paper
• Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.

  2011cited by this paper
• Novel Metagenome-Derived Carboxylesterase That Hydrolyzes β-Lactam Antibiotics

  2011cited by this paper
• The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health?

  2011cited by this paper
• Effects of Gut Microflora on Pharmacokinetics of Hesperidin: A Study on Non-Antibiotic and Pseudo-Germ-Free Rats

  2010cited by this paper
• Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

  2010cited by this paper
• Efflux-Mediated Drug Resistance in Bacteria

  2009cited by this paper
• Effect of glycosidation of isoflavones on their bioavailability and pharmacokinetics in aged male rats.

  2009cited by this paper
• The role of gut microbiota in drug response.

  2009cited by this paper
• Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

  2009cited by this paper
• Esterase SeE of Streptococcus equi ssp. equi is a novel nonspecific carboxylic ester hydrolase.

  2008cited by this paper
• Conversion of Daidzein and Genistein by an Anaerobic Bacterium Newly Isolated from the Mouse Intestine

  2008cited by this paper
• Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria.

  2008cited by this paper
• The gastrointestinal microbiota as a site for the biotransformation of drugs.

  2008cited by this paper
• Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine.

  2007cited by this paper
• Two membrane proteins from Bifidobacterium breve UCC2003 constitute an ABC-type multidrug transporter.

  2006cited by this paper
• Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Ranitidine in Healthy Human Volunteers: A Possible Role of P-Glycoprotein

  2006cited by this paper
• Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions

  2005cited by this paper
• Antibiotic resistance in food lactic acid bacteria--a review.

  2005cited by this paper
• The use of formulation technology to assess regional gastrointestinal drug absorption in humans.

  2004cited by this paper
• ATP-binding cassette transporters in bacteria.

  2004cited by this paper
• The ATP Binding Cassette Multidrug Transporter LmrA and Lipid Transporter MsbA Have Overlapping Substrate Specificities*

  2003cited by this paper
• An in vitro Study on the Active Conversion of Flucytosine to Fluorouracil by Microorganisms in the Human Intestinal Microflora

  2003cited by this paper
• Metabolism of kalopanaxsaponin K by human intestinal bacteria and antirheumatoid arthritis activity of their metabolites.

  2002cited by this paper
• Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora.

  2002cited by this paper
• A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals

  2002cited by this paper
• The Mucosa of the Small Intestine

  2002cited by this paper
• Intestinal bacterial beta-glucuronidase activity of patients with colon cancer.

  2001cited by this paper
• Colonic metabolism of ranitidine: implications for its delivery and absorption.

  2001cited by this paper
• Intestinal bacterial β-glucuronidase activity of patients with colon cancer

  2001cited by this paper
• Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients.

  2001cited by this paper
• Molecular Properties of Bacterial Multidrug Transporters

  2000cited by this paper
• Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities

  2000cited by this paper
• Degradation of quercetin‐3‐glucoside in gnotobiotic rats associated with human intestinal bacteria

  2000cited by this paper
• Is the role of the small intestine in first-pass metabolism overemphasized?

  1999cited by this paper
• Intestinal bacterial metabolism of flavonoids and its relation to some biological activities

  1998cited by this paper
• Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.

  1998cited by this paper
• Reduction of nitrazepam by Clostridium leptum, a nitroreductase-producing bacterium isolated from the human intestinal tract.

  1997cited by this paper
• Degradation of Insulin and Calcitonin and Their Protection by Various Protease Inhibitors in Rat Caecal Contents: Implications in Peptide Delivery to the Colon

  1997cited by this paper
• The Role of Mammalian Intestinal Bacteria in the Reductive Metabolism of Zonisamide

  1997cited by this paper
• Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil.

  1997cited by this paper
• Increased systemic availability of loperamide after oral administration of loperamide and loperamide oxide with cotrimoxazole.

  1996cited by this paper
• Bioavailability Study of Glycyrrhetic Acid after Oral Administration of Glycyrrhizin in Rats; Relevance to the Intestinal Bacterial Hydrolysis

  1996cited by this paper
• Metabolism of peptide drugs by the microorganisms in rat cecal contents.

  1995cited by this paper
• Purification and characterization of beta-glucuronidase from Escherichia coli HGU-3, a human intestinal bacterium.

  1995cited by this paper
• Metabolism of omeprazole by gut flora in rats.

  1995cited by this paper
• Reduction of the prodrug loperamide oxide to its active drug loperamide in the gut of rats, dogs, and humans.

  1995cited by this paper
• The metabolism and excretion of risperidone after oral administration in rats and dogs.

  1994cited by this paper
• Comparative developmental toxicity and metabolism of nitrazepam in rats and mice.

  1993cited by this paper
• The role of intestinal bacteria in the transformation of sodium picosulfate.

  1992cited by this paper
• The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slices.

  1992cited by this paper
• Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria.

  1991cited by this paper
• Sulphasalazine in ulcerative colitis: in memoriam?

  1991cited by this paper
• Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease.

  1991cited by this paper
• Intestinal microflora: metabolism of drugs and carcinogens.

  1990cited by this paper
• Beta-glucuronidase activity related to bacterial growth in common bile duct bile in gallstone patients.

  1988cited by this paper
• Porcine intestinal ammonia liberation. Influence of food intake, lactulose and neomycin treatment.

  1988cited by this paper
• The role of intestinal microflora in the formation of the methylthio adduct metabolites of paracetamol. Studies in neomycin-pretreated and germ-free mice.

  1988cited by this paper
• The reduction of sulphinpyrazone and sulindac by intestinal bacteria.

  1987cited by this paper
• Role of the intestinal flora in the acetylation of sulfasalazine metabolites.

  1987cited by this paper
• Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid

  1985cited by this paper
• Role of the intestinal microflora in clonazepam metabolism in the rat.

  1984cited by this paper
• Intestinal microflora as potential modifiers of sensitizer activity in vivo.

  1984cited by this paper
• Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide

  1983cited by this paper
• Metabolism of digoxin and absorption site.

  1982cited by this paper
• Inactivation of digoxin by the gut flora: reversal by antibiotic therapy.

  1981cited by this paper
• Role of the intestinal flora in the metabolism of misonidazole.

  1980cited by this paper
• Metabolism of sennosides by human intestinal bacteria.

  1980cited by this paper
• Metabolism of Sennosides by Human Intestinal Bacteria

  1980cited by this paper
• Acetamide--a metabolite of metronidazole formed by the intestinal flora.

  1979cited by this paper
• The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid.

  1979cited by this paper
• Metabolism of drugs and other foreign compounds by intestinal microorganisms.

  1978cited by this paper
• Metabolism of N-acylated and O-alkylated drugs by the intestinal microflora during anaerobic incubation in vitro.

  1974cited by this paper

• The association between the oral microbiome and hypertension: a systematic review

  2025cites this paper
• Insights into the Role of Gut Microbiota Modulation in the Management of Various Cardiovascular Diseases: A New Approach for Improving the Efficacy of Current Cardiovascular Medications.

  2025cites this paper
• Drugs Versus Microbiota: How Pharmacotherapy Affects Gut and Probiotic Bacteria

  2025cites this paper
• Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy.

  2025cites this paper
• The Gut Microbiota’s Role in Drug Absorption, Metabolism and Efficacy: Implications for Personalized Medicine

  2025cites this paper
• An integrated platform for investigating drug-microbial interactions to support pharmacomicrobiomics studies.

  2024cites this paper
• Fecal microbiota transplantation for the treatment of intestinal and extra‐intestinal diseases: Mechanism basis, clinical application, and potential prospect

  2024cites this paper
• Perspectives on the involvement of the gut microbiota in salt-sensitive hypertension

  2024cites this paper
• Microbial influence on blood pressure: unraveling the complex relationship for health insights

  2024cites this paper
• S-amlodipine induces liver inflammation and dysfunction through the alteration of intestinal microbiome in a rat model

  2024cites this paper
• Antibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe Drugs

  2023cites this paper
• Pharmacokinetic Profiling of Ginsenosides, Rb1, Rd, and Rg3, in Mice with Antibiotic-Induced Gut Microbiota Alterations: Implications for Variability in the Therapeutic Efficacy of Red Ginseng Extracts

  2023cites this paper
• Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats

  2023cites this paper
• Sexual Dimorphic Interplays Between Gut Microbiota and Antihypertensive Drugs

  2023cites this paper
• Alterations of gut microbiota are associated with blood pressure: a cross-sectional clinical trial in Northwestern China

  2023cites this paper
• Interaction of drugs with gut microbiota modulators

  2023cites this paper
• Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions

  2023cites this paper
• Associations between gastrointestinal symptoms, medication use, and spontaneous drug discontinuation in patients with major depressive disorder in China.

  2022cites this paper
• Gut Microbiota as the Potential Mechanism to Mediate Drug Metabolism Under High-Altitude Hypoxia.

  2022cites this paper
• Development of an in vitro Model of Human Gut Microbiota for Screening the Reciprocal Interactions With Antibiotics, Drugs, and Xenobiotics

  2022cites this paper
• Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors

  2022cites this paper
• Mechanism-Based Pharmacokinetic Model for the Deglycosylation Kinetics of 20(S)-Ginsenosides Rh2

  2022cites this paper
• Resistance to Antihypertensive Drugs: Is Gut Microbiota the Missing Link?

  2022cites this paper
• Human Gut Microbiota and Drug Metabolism

  2022cites this paper
• Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope

  2022cites this paper
• Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment

  2022cites this paper
• Homology study between human drug metabolizing enzymes and intestinal microbial metabolizing enzymes

  2021cites this paper
• Ginkgo biloba leaf extract suppresses intestinal human breast cancer resistance protein expression in mice: Correlation with gut microbiota.

  2021cites this paper
• Antihypertensive medication adherence trends by sex and drug class: A pilot study

  2021cites this paper
• The bacterial gut microbiome of probiotic-treated very-preterm infants: changes from admission to discharge

  2021cites this paper
• Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug

  2021cites this paper
• Mikrobiota jelitowa a leki. Interakcje wpływające na skuteczność i bezpieczeństwo farmakoterapii

  2021influential citation
• Role of the microbiota in hypertension and antihypertensive drug metabolism

  2021cites this paper
• Refractoriness to drugs in migraine may be the result of developing anti-drug antibodies.

  2020cites this paper
• Impact drugs targeting cardiometabolic risk on the gut microbiota.

  2020cites this paper
• Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism

  2020cites this paper
• Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.

  2020cites this paper
• Intestinal absorption and distribution of naringin, hesperidin, and their metabolites in mice

  2020cites this paper
• Sensitivity to Morphine Reward Associates With Gut Dysbiosis in Rats With Morphine-Induced Conditioned Place Preference

  2020cites this paper
• Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity

  2020cites this paper
• Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats

  2020cites this paper
• Maternal Treatment With Captopril Persistently Alters Gut-Brain Communication and Attenuates Hypertension of Male Offspring

  2020cites this paper
• Systems biology, drug development, and clinical outcomes

  2020cites this paper
• Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes.

  2019cites this paper
• Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases

  2019cites this paper
• Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension.

  2019cites this paper
• Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model

  2019cites this paper
• The Role of the Gut-Brain Axis in Attention-Deficit/Hyperactivity Disorder.

  2019cites this paper
• Human Organ-on-a-Chip: Around the Intestine Bends

  2018cites this paper
• Population-Based Gut Microbiome Associations With Hypertension.

  2018cites this paper
• Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug–microbiome interactions

  2018cites this paper